Consistent with our previous results, NLRP3, Caspase-1, and IL-1β levels were higher in lower-risk MDS-MSCs but showed no differences between higher-risk MDS-MSCs and normal controls (Figure 3B). This evidence concerns the gene NLRP3 and myelodysplastic syndrome.